Autor:	Irene Treviño-Frenk, Eli Skromne-Eisenberg, Verónica Rivas-Alonso, Manuel De la Maza-Flores, Luis Enrique Amaya-Sánchez, Merced Velázquez-Quintana, Laura Ordoñez-Boschetti, Leonardo Llamas-López, Brenda Bertado-Cortés, Sandra Quiñones-Aguilar, Victor Gonzalez-Amezquita
Rok vydání:	2020
Předmět:	medicine.medical_specialty Neuropsychology and Physiological Psychology Neurology business.industry Public Health Environmental and Occupational Health medicine Ocrelizumab Medical physics Neurology (clinical) business medicine.drug
Zdroj:	Revista Mexicana de Neurociencia. 21
ISSN:	2604-6180
DOI:	10.24875/rmn.20000153
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c4988973b0a4a87dc2e5f0d3841d713a https://doi.org/10.24875/rmn.20000153 Zobrazit plný text záznamu